Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology

PLoS Genetics

Volumn 4, Issue 7, 2008, Pages

  Siew, Hong Lam ^a   Mathavan, Sinnakarupan ^b   Tong, Yan ^a   Li, Haixia ^b   Karuturi, R Krishna Murthy ^b   Wu, Yilian ^a   Vega, Vinsensius B ^b   Liu, Edison T ^b   Gong, Zhiyuan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BIOLOGICAL MARKER; ESTROGEN; ESTROGEN RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON; AROMATIC HYDROCARBON; ZEBRAFISH PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOGENOMICS; CONTROLLED STUDY; DATA MINING; GENE EXPRESSION PROFILING; GENOMICS; GENOTOXICITY; HIGH THROUGHPUT SCREENING; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; RISK ASSESSMENT; SEQUENCE HOMOLOGY; UNINDEXED SEQUENCE; ZEBRA FISH; ANIMAL; ANIMAL MODEL; DNA MICROARRAY; DRUG EFFECT; ECONOMICS; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

DANIO RERIO; INVERTEBRATA; RODENTIA; VERTEBRATA;

ANIMALS; BIOLOGICAL MARKERS; ESTROGENS; GENE EXPRESSION; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; HYDROCARBONS, AROMATIC; MALE; MODELS, ANIMAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 48249107971     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000121     Document Type: Article

References (50)

1. Bredel M, Jacoby E (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5: 262-275.
2. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, et al. (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotech 119: 219-244.
3. Custodia N, Won SJ, Novillo A, Wieland M, Li C, et al. (2001) Caenorhabditis elegans as an environmental monitor using DNA microarray analysis. Ann NY Acad Sci 948: 32-42.
4. Reichert K, Menzel R (2005) Expression profiling of five different xenobiotics using a Caenorhabditis elegans whole genome microarray. Chemosphere 61:229-237.
5. Girardot F, Monnier V, Tricoire H (2004) Genome wide analysis of common and specific stress responses in adult Drosophila melanogaster. BMC Genomics 30: 74.
6. Pedra JH, McIntyre LM, Scharf ME, Pittendrigh BR (2004) Genome-wide transcription profile of field- and laboratory-selected dichlorodiphenyltrichloroethane (DDT)-resistant Drosophila. Proc Natl Acad Sci U S A 101: 7034-7039.
7. Boess F, Kamber M, Romer S, Gasser R, Muller D, et al. (2003) Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci 73: 386-402.
8. Dooley K, Zon LI (2000) Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev 10: 252-256.
9. Zon LI, Peterson RT (2005) In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4: 35-44.
10. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR, et al. (2003) Chemical discovery and global gene expression analysis in zebrafish. Nat Biotechnol 21: 879-883.
11. Cossins AR, Crawford DL (2005) Fish as models for environmental genomics. Nat Rev Genet 6: 324-333.
12. Parng C, Seng WL, Semino C, McGrath P (2002) Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 1: 41-48.
13. Hill AJ, Teraoka H, Heideman W, Peterson RE (2005) Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86: 6-19.
14. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, et al. (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 24: 73-75.
15. Lam SH, Winata CL, Tong Y, Korzh S, Lim WS, et al. (2006) Transcriptome kinetics of arsenic-induced adaptive response in zebrafish liver. Physiol Genomics 27: 351-361.
16. Yang L, Yang L, Kemadjou JR, Zinsmeister C, Bauer M, Legradi J, et al. (2007) Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biol. 8: R227.
17. Safe S, Wormke M (2003) Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 16: 807-816.
18. Matthews J, Gustafsson JA (2006) Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl Recept Signal 4: e016.
19. Nilsson S, Gustafsson JA (2002) Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 37: 1-28.
20. Fried KW, Schneider CM, Schramm KW, Datta A, Chahbane N, et al. (2007) From Dioxin to Drug Lead-The Development of 2,3,7,8-Tetrachlorophenothiazine. ChemMedChem 2: 890-897.
21. Safe S, McDougal A (2002) Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers. Int J Oncol 20: 1123-1128.
22. Dobs A, Darkes MJ (2005) Incidence and management of gynecomastia in men treated for prostate cancer. J Urol 174: 1737-1742.
23. Yang M, Park MS, Lee HS (2006) Endocrine disrupting chemicals: human exposure and health risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 24: 183-224.
24. Luch A (2005) Nature and nurture-lessons from chemical carcinogenesis. Nat. Rev. Cancer 5: 113-125.
25. Xu C, Li CY, Kong AN (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28: 249-268.
26. Rotchell JM, Ostrander GK (2003) Molecular markers of endocrine disruption in aquatic organisms. J Toxicol Environ Health B Crit Rev 6: 453-496.
27. Wang DY, McKague B, Liss SN, Edwards EA (2004) Gene expression profiles for detecting and distinguishing potential endocrine-disrupting compounds in environmental samples. Environ Sci Technol 38: 6396-6406.
28. Lewis RJ (1996) Sax's Dangerous Properties of Industrial Materials. 9th ed. New York: Van Nostrand Reinhold. pp 357.
29. Agency for Toxic Substances and Disease Registry (ATSDR) (1995) Toxicological profile for Polycyclic Aromatic Hydrocarbons (PAHs). Atlanta: U S Department of Health and Human Services, Public Health Service. pp 458.
30. Wang H, Tan JT, Emelyanov A, Korzh V, Gong Z (2005) Hepatic and extrahepatic expression of vitellogenin genes in the zebrafish, Danio rerio. Gene 356: 91-100.
31. Zhang W, Andersson S, Cheng G, Simpson ER, Warner M, et al. (2003) Update on Estrogen Signaling. FEBS Letters 546: 17-24.
32. Beischlag TV, Perdew GH (2005) ER α-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J Biol Chem 280: 21607-21611.
33. Ostlund H, Keller E, Hurd YL (2003) Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann NY Acad Sci 1007: 54-63.
34. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, et al. (2003) Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genet 35: 171-175.
35. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, et al. (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61: 300-308.
36. Dvorak Z, Vrzal R, Pavek P, Ulrichova J (2007) An evidence for regulatory cross-talk between aryl hydrocarbon receptor and glucocorticoid receptor in HepG2 cells. Physiol Res. In press.
37. Sonneveld E, Jonas A, Meijer OC, Brouwer A, van der Burg B (2007) Glucocorticoid-Enhanced expression of dioxin target genes through regulation of the rat aryl hydrocarbon receptor. Toxicol Sci 99: 455-469.
38. Fang L, Ricketson D, Getubig L, Darimont B (2006) Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain. Proc Natl Acad Sci U S A 103: 18487-18492.
39. Caruso JA, Laird DW, Batist G (1999) Role of HSP90 in mediating cross-talk between the estrogen receptor and the Ah receptor signal transduction pathways. Biochem Pharmacol 58: 1395-1403.
40. Aittomäki S, Pesu M, Groner B, Jänne OA, Palvimo JJ, et al. (2000) Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J Immunol 164: 5689-1597.
41. Nebert DW, Puga A, Vasiliou V (1993) Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann NY Acad Sci 685: 624-640.
42. Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, et al. (2007) Human X-Box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 21: 4013-4027.
43. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529.
44. Kostova Z, Wolf DH (2003) For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J 22: 2309-2317.
45. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4: 966-977.
46. Bayliss PE, Bellavance KL, Whitehead GG, Abrams JM, Aegerter S, et al. (2006) Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol 2: 265-273.
47. Pritchard JF (2003) Making better drugs: Decision gates in non-clinical drug development. Nature Rev Drug Discov 2: 542-553.
48. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3: 711-715.
49. Eisen MB, Brown PO (1999) DNA arrays for analysis of gene expression. Methods Enzymol 303: 179-205.
50. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.